Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

At this stage I highly doubt that any remaining IPCI long could care less about the terms a potential partner suitor on either Regabatin or Rexista would demand.

Even if both potential partnership deals weren't very lucrative for IPCI and perfectly reflected the weakness stage IPCI's market is currently languishing at...it would finally once and for all remove all the lingering doubts about Dr. Odidi's abilities and IPCI's ongoing cash constraints!

Most importantly it would then position IPCI with enough cash to start submitting their other 20 opioid based NDA's and initiate trials on PODRAS which is a potential game changer of global proportions.

Whatever IPCI's plans were 4 years ago on utilizing the cash garnered from their fully commercialized ANDA's is beyond old news now...and it's beyond high time that Dr. Odidi recognizes that major adjustments need to be made while the opportunity to do so still exists.

I just can't understand how Dr. Odidi could do such a phenomenal job as CEO over IPCI's 1st 4+ years then allow IPCI to careen so far off the tracks over the past 3.5 years mainly due to the FDA not granting them ANDA approvals in a timely enough fashion.

And the only possible explanation for it is the simple fact that Dr. Odidi is a brilliant scientist but not an equally brilliant CEO.

Sign some damn deals on Rexista and Regabatin already and partner PODRAS development with the Rexista deal.

The real value here has always been in proving the proprietary delivery tech platform within the NDA's and over the past 2 years not a single shred of value has been unlocked by IPCI going it alone on Regabatin, Rexista and PODRAS which is why ZERO institutions support IPCI.